2003
DOI: 10.1016/s0022-2836(03)00640-5
|View full text |Cite
|
Sign up to set email alerts
|

NFATc1 with AP-3 Site Binding Specificity Mediates Gene Expression of Prostate-specific-membrane-antigen

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
22
0

Year Published

2004
2004
2023
2023

Publication Types

Select...
7
2
1

Relationship

1
9

Authors

Journals

citations
Cited by 32 publications
(23 citation statements)
references
References 29 publications
1
22
0
Order By: Relevance
“…It lacks typical TATA or CAAT boxes but possesses purine-rich sequences, which is in agreement with human and mouse promoters [22]. AiECSOD has an AP-3 binding site which is recognized by the NFAT (nuclear factors in activated T cells) family in immune cells that express cytokine [38]. AiECSOD also has binding sites for Oct-1 and Oct-2.1 which are ubiquitously expressed POU domain transcription factors and are essential for post-translational modification [39,40].…”
Section: Speciessupporting
confidence: 55%
“…It lacks typical TATA or CAAT boxes but possesses purine-rich sequences, which is in agreement with human and mouse promoters [22]. AiECSOD has an AP-3 binding site which is recognized by the NFAT (nuclear factors in activated T cells) family in immune cells that express cytokine [38]. AiECSOD also has binding sites for Oct-1 and Oct-2.1 which are ubiquitously expressed POU domain transcription factors and are essential for post-translational modification [39,40].…”
Section: Speciessupporting
confidence: 55%
“…The consensus binding sequence of AP3 is similar to the binding sites of NFkB and NFATc1 (McCaffrey et al 1992, Lee et al 2003. Therefore, the possibility arises that the AP3 binding activity found in the rat luteal cells could be due to NFkB or NFATc1.…”
Section: Characterization Of the Luteal Ap3 Binding Proteinmentioning
confidence: 99%
“…A 10 nmol/L final concentration of R1881 was added. Nuclear extracts were collected as described previously (21). Nuclear extracts (100 g) were preincubated with 4 g of AR-PG21 antibodies (Upstate Biotechnology) for 3 hours at 4°C, followed by adding protein A/G agarose (Santa Cruz Biotechnology).…”
Section: Introductionmentioning
confidence: 99%